Assess the risk for genetic predisposition towards cardiovascular diseases.
Cardiovascular Diseases (CVD) are often caused by a combination of a genetic predisposition and an unhealthy lifestyle. CVD StripAssays® and RealFast™ Assays identify various combinations of genetic CVD risk factors.
Cardiovascular Diseases (CVD)
- The two major manifestations of CVD are atherosclerosis and venous thrombosis.
- The risk for atherosclerosis is increased by the combination of an unhealthy lifestyle and variants of genes involved in endothelial dysfunction, hyperlipidemia, hypertension, and inflammation.
- Correspondingly, the interplay of adverse influences (female hormone intake, lack of physical activity, surgery, cancer) and certain genetic variants enhance the susceptibility to develop thrombosis.
- Testing for disease-associated genetic variants in conjunction with an adaptation of life style can greatly contribute to decrease an individual’s CVD risk.
Products
| Name | REF | Unit Size | IFU | Brochure |
|---|---|---|---|---|
| FV-PTH-MTHFR StripAssay® | 4-260 | 20 tests |
|
|
| Apo E StripAssay® | 4-280 | 20 tests |
|
|
| FV-PTH StripAssay® | 4-290 | 20 tests |
|
|
| CVD StripAssay® T | 4-360 | 20 tests |
|
|
| CVD StripAssay® A | 4-370 | 20 tests |
|
|
| FV Leiden RealFast™ Assay | 7-110 7-113 | 100 rxn 32 rxn |
|
|
| FV-PTH mpx RealFast™ Assay | 7-115 7-118 | 100 rxn 32 rxn |
|
|
| PTH 20210G>A RealFast™ Assay | 7-120 7-123 | 100 rxn 32 rxn |
|
|
| MTHFR 677C>T RealFast™ Assay | 7-160 7-163 | 100 rxn 32 rxn |
|
|
| MTHFR mpx RealFast™ Assay | 7-165 7-168 | 100 rxn 32 rxn |
|
|
| MTHFR 1298A>C RealFast™ Assay | 7-170 7-173 | 100 rxn 32 rxn |
|
|
| PAI-1 4G/5G RealFast™ Assay | 7-180 7-183 | 100 rxn 32 rxn |
|
|
| FGB -455G>A RealFast™ Assay | 7-230 7-233 | 100 rxn 32 rxn |
|
|
| FXII 46C>T RealFast™ Assay | 7-240 7-243 | 100 rxn 32 rxn |
|
|
| FXIII V34L RealFast™ Assay | 7-250 7-253 | 100 rxn 32 rxn |
|